UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Okabena Investment Services Inc.

Okabena Investment Services Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 22.4% during the third quarter, HoldingsChannel reports. The firm owned 4,440 shares of the healthcare conglomerate’s stock after selling 1,281 shares during the period. UnitedHealth Group comprises about 0.7% of Okabena Investment Services Inc.’s investment portfolio, making the stock its 26th biggest holding. Okabena Investment Services Inc.’s holdings in UnitedHealth Group were worth $2,596,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Truepoint Inc. grew its position in UnitedHealth Group by 45.2% in the 3rd quarter. Truepoint Inc. now owns 1,082 shares of the healthcare conglomerate’s stock valued at $633,000 after buying an additional 337 shares during the last quarter. KKM Financial LLC boosted its holdings in shares of UnitedHealth Group by 5.2% in the third quarter. KKM Financial LLC now owns 5,233 shares of the healthcare conglomerate’s stock valued at $3,060,000 after acquiring an additional 259 shares in the last quarter. Algert Global LLC purchased a new position in UnitedHealth Group during the third quarter worth about $1,763,000. Canopy Partners LLC increased its position in UnitedHealth Group by 1.9% during the 3rd quarter. Canopy Partners LLC now owns 4,450 shares of the healthcare conglomerate’s stock worth $2,602,000 after purchasing an additional 81 shares during the period. Finally, Kingsview Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 4.1% in the 3rd quarter. Kingsview Wealth Management LLC now owns 10,461 shares of the healthcare conglomerate’s stock valued at $6,116,000 after buying an additional 416 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

Shares of UnitedHealth Group stock opened at $590.87 on Friday. The firm has a market cap of $543.77 billion, a PE ratio of 38.49, a P/E/G ratio of 1.75 and a beta of 0.58. The business’s fifty day moving average is $582.63 and its two-hundred day moving average is $552.95. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Upgrades and Downgrades

A number of research firms have commented on UNH. Stephens reduced their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Barclays decreased their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.